Rosenblatt Maintains Buy on Dolby Laboratories, Lowers Price Target to $85
Benzinga Newsdesk 11 months ago
NewsPrice TargetAnalyst Ratings
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $95 to $85.
Rosenblatt analyst Steven Frankel maintains Dolby Laboratories (NYSE:DLB) with a Buy and lowers the price target from $95 to $85.